A cost–benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus-Reference-Cited by-同舟云学术

A cost–benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus

Published:2010-11 Issue:49 Volume:28 Page:7797-7802
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Fischinger J.M.,Stephan B.,Wasserscheid K.,Eichler H.,Gärtner B.C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Paul Ehrlich Institut. Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) gemäß §§ 12 und 18 des Transfusionsgesetzes (TFG) (Novelle 2005). Bundesanzeiger 2005;209:1576457.

2. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000–2002: risk of virus transmission and the impact of nucleic acid amplification testing;Offergeld;Eurosurveillance,2005

3. Blood screening for HBV DNA;Fang;Journal of Clinical Virology,2006

4. Hepatitis B A reveiw of the role of NAT in enhancing blood safety;Lelie;Journal of Clinical Virology,2006

5. Hepatitis-Impfung von Blutspendern: notwendig, machbar, bezahlbar?;Gerlich;Transfusion Medicine and Hemotherapy,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The health and social impact of Blood Donors Associations: A Social Return on Investment (SROI) analysis;Evaluation and Program Planning;2019-04

2. Health Economics in Blood Safety;Blood Safety;2018-09-27

3. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C vir;Transfusion;2017-02-05

4. Economic evaluation of HBV vaccination: A systematic review of recent publications (2000–2013);Human Vaccines & Immunotherapeutics;2016-04-22

5. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders;Blood Reviews;2016-01